About the Partnership
The Global Partnership for Zero Leprosy is a coalition of individuals and organizations committed to ending leprosy, also known as Hansen’s disease. The Partnership includes Novartis, the World Health Organization (WHO, as an observer), the International Federation of Anti-Leprosy Associations (ILEP), the Sasakawa Health Foundation, and the International Association for Integration, Dignity and Economic Advancement (IDEA). It also includes representatives from the national leprosy programmes of Brazil, Ghana, and India, the International Leprosy Association, scientific organizations, and the academic community. The Secretariat for the Partnership is located at the Task Force for Global Health.